Literature DB >> 15377824

Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.

Hüsnü Gökaslan1, Levent Türkeri, Zehra Neşe Kavak, Funda Eren, Alper Sişmanoğlu, Sennur Ilvan, Fatih Durmuşoğlu.   

Abstract

BACKGROUND/AIM: To investigate the expression and value for diagnosis of the genes, p53 and pTEN, the protein, Ki-67, and the receptors, estrogen and progesterone, in differentiating smooth muscle tumors of the uterus. MATERIAL AND
METHOD: Seventeen samples of leiomyosarcoma, 2 smooth muscle tumors with uncertain malignant potential (STUMP), 9 atypical myomas and 15 leiomyomas were stained immunohistochemically. The chi(2) test was used for the statistical analysis of the data.
RESULTS: The malignant side of the spectrum was strongly stained for Ki-67 and p53 while uniformly decreasing toward the benign tumors. The results were found to be statistically significant (p < 0.0001). The staining for progesterone receptor was also statistically significant, but the tumors that were considered benign, such as leiomyoma and atypical myoma, were the ones strongly stained (p = 0.005). The expression of estrogen receptor was significant in these tumors, but the p value was very close to the cut-off value (p = 0.07). As the degree of differentiation of the tumor increased, the trend showed stronger staining for estrogen receptor. However, no difference was detected in the staining properties of the tumors for pTEN (p = 0.2457).
CONCLUSION: The expression of Ki-67, p53 and progesterone receptors is promising in immunodifferentiation of smooth muscle tumors of the uterus with malignant potential. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377824     DOI: 10.1159/000080933

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  9 in total

1.  Recurrent renal giant leiomyosarcoma.

Authors:  Salih Erpulat Öziş; Kamil Gülpınar; Zafer Şahlı; Baha Burak Konak; Mete Keskin; Süleyman Özdemir; Ömür Ataoğlu
Journal:  Ulus Cerrahi Derg       Date:  2014-12-25

2.  Two Subtypes of Atypical Leiomyoma: Clinical, Histologic, and Molecular Analysis.

Authors:  Julianne M Ubago; Qing Zhang; Julie J Kim; Beihua Kong; Jian-Jun Wei
Journal:  Am J Surg Pathol       Date:  2016-07       Impact factor: 6.394

3.  Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant.

Authors:  Knapp Paweł; Adrian Chabowski; Jan Górski
Journal:  Lipids       Date:  2012-12-14       Impact factor: 1.880

4.  Immunohistochemical detection of promyelocytic leukemia zinc finger and histone 1.5 in uterine leiomyosarcoma and leiomyoma.

Authors:  Mazdak Momeni; Tamara Kalir; Sara Farag; Yayoi Kinoshita; Taisha Y Roman; Linus Chuang; David A Fishman; David E Burstein
Journal:  Reprod Sci       Date:  2014-04-30       Impact factor: 3.060

5.  Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.

Authors:  Riitta Koivisto-Korander; Ralf Butzow; Anna-Maija Koivisto; Arto Leminen
Journal:  Tumour Biol       Date:  2010-12-16

6.  Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases.

Authors:  Jean V Fischer; Melissa Mejia-Bautista; Brian Vadasz; Ping Yin; Serdar Bulun; Edward J Tanner; Xinyan Lu; Jian-Jun Wei
Journal:  Int J Gynecol Pathol       Date:  2022-01-31       Impact factor: 3.326

7.  Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma.

Authors:  Yun Liang; Xiaofei Zhang; Xiaoduan Chen; Weiguo Lü
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

8.  Retroperitoneal smooth muscle tumor of uncertain malignant potential after hysterectomy: a case report.

Authors:  Hye Sung Won; Hoo Geun Chun; Kyungji Lee
Journal:  J Med Case Rep       Date:  2011-05-28

9.  Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors.

Authors:  Iman H Hewedi; Nehal A Radwan; Lobna S Shash
Journal:  Diagn Pathol       Date:  2012-01-05       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.